GT-2104

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGT-2104
Drug Alias NameGT-2104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsAnxietyMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesMgi Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMgi Pharma
Active IndicationsN/A
Inactive IndicationsAnxietyMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A